Short-Supply Prescription Drugs: Shining a Light on the Gray Market
WASHINGTON, D.C.—The U.S. Senate Committee on Commerce, Science, and Transportation will hold a hearing examining the so-called “gray market” drug companies who drive up the cost of short-supply prescription drugs. The hearing will explore how and why hospitals and other health care providers sometimes struggle to obtain short-supply prescription drugs they need to treat patients suffering from cancer and other life-threatening conditions. This hearing is the result of a joint Congressional investigation by Chairman John D. (Jay) Rockefeller IV, Senator Tom Harkin, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, and Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform.